Kannan Siddarth, Gillespie Conor S, Hanemaaijer Jeremy, Eraifej John, Alalade Andrew F, Green Alex
School of Medicine, University of Central Lancashire, Preston PR1 7BH, United Kingdom.
Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 1PG, United Kingdom.
Pain Med. 2025 May 1;26(5):269-278. doi: 10.1093/pm/pnaf001.
Deep brain stimulation (DBS) and motor cortex stimulation (MCS) are invasive interventions in order to treat various neuropathic pain syndromes such as central post-stroke pain (CPSP). While each treatment has varying degree of success, comparative analysis has not yet been performed, and the success rates of these techniques using validated, objective pain scores have not been synthesized.
A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. Three databases were searched, and articles published from January 2000 to October 2024 were included (last search date October 25, 2024). Meta-Analysis was performed using random effects models. We evaluated the performance of DBS or MCS by assessing studies that reported pain relief using visual analogue scale (VAS) or numerical rating scale (NRS) scores.
Of the 478 articles identified, 32 were included in the analysis (330 patients-139 DBS and 191 MCS). The improvement in mean VAS score for patients that underwent DBS post-surgery was 48.6% compared to a score of 53.1% for patients that had MCS. The pooled number of patients who improved after DBS was 0.62 (95% CI, 0.51-0.71, I2 = 16%). The pooled number of patients who improved after MCS was 0.64 (95% CI, 0.53-0.74, I2 = 40%).
The use of neurosurgical interventions such as DBS and MCS are last-resort treatments for CPSP, with limited studies exploring and comparing these two techniques. While our study shows that MCS might be a slightly better treatment option, further research would need to be done to determine the appropriate surgical intervention in the treatment of CPSP.
深部脑刺激(DBS)和运动皮层刺激(MCS)是用于治疗各种神经性疼痛综合征(如中风后中枢性疼痛,CPSP)的侵入性干预措施。虽然每种治疗方法都有不同程度的成功率,但尚未进行比较分析,且尚未综合使用经过验证的客观疼痛评分来评估这些技术的成功率。
按照PRISMA指南进行系统评价和荟萃分析。检索了三个数据库,纳入了2000年1月至2024年10月发表的文章(最后检索日期为2024年10月25日)。使用随机效应模型进行荟萃分析。我们通过评估报告使用视觉模拟量表(VAS)或数字评分量表(NRS)评分来缓解疼痛的研究,来评估DBS或MCS的疗效。
在识别出的478篇文章中,32篇被纳入分析(330例患者——139例接受DBS,191例接受MCS)。接受DBS手术后患者的平均VAS评分改善率为48.6%,而接受MCS的患者为53.1%。DBS术后改善的患者合并数为0.62(95%置信区间,0.51 - 0.71,I² = 16%)。MCS术后改善的患者合并数为0.64(95%置信区间,0.53 - 0.74,I² = 40%)。
DBS和MCS等神经外科干预措施是治疗CPSP的最后手段,探索和比较这两种技术的研究有限。虽然我们的研究表明MCS可能是一个稍好的治疗选择,但仍需要进一步研究以确定治疗CPSP的合适手术干预措施。